Last reviewed · How we verify
NCT06128200
NEUROMARK Randomized Controlled Trial
NA trial testing NEUROMARK System in Chronic Rhinitis in 132 participants. Completed in 26 November 2025.
26 November 2025
Quick facts
| Lead sponsor | Neurent Medical |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 132 |
| Start date | 10 October 2023 |
| Primary completion | 26 November 2025 |
| Estimated completion | 26 November 2025 |
| Sites | 16 locations across United States |
Drugs / interventions tested
- NEUROMARK System
- Sham NEUROMARK System
Conditions studied
- Chronic Rhinitis — all drugs for Chronic Rhinitis →
Sponsor
Neurent Medical — full company profile →
Who can join
18 and older, any sex, with Chronic Rhinitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The NEUROMARK RCT Study is a prospective, multicenter, randomized, sham-controlled, single-blinded, superiority trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06128200
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NEUROMARK System
Trials testing the same drug.
- NCT05591989 — Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) · NA · completed
- NCT05324397 — Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY) · NA · completed
Other recruiting trials for Chronic Rhinitis
Currently open trials in the same condition.
- NCT06999044 — Study on the Optimization of the Diagnostic Process for Chronic Rhinitis Using Nasal Allergen Provocation Test · recruiting
- NCT06370468 — The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis · recruiting
Other Neurent Medical trials
Trials by the same sponsor.
- NCT05591989 — Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) · NA · completed
- NCT05324397 — Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY) · NA · completed
- NCT04769596 — Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06128200 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neurent Medical
- Last refreshed: 19 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06128200.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing